Safety, Tolerability, and Pharmacokinetics (PK) of Single and Multiple Ascending Oral Doses of XEN1101.
Clinical trial NCT03340220 · COMPLETED
Trial details
- NCT number
- NCT03340220
- Sponsor
- Xenon Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-13
- Primary completion
- 2021-11-26
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.